Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.55 GBX | -1.45% |
|
-4.91% | +49.72% |
May. 01 | Poolbeg Pharma Secures Full Patent in US for Immunomodulator II | MT |
May. 01 | Poolbeg Pharma celebrates full patent approval for Immunomodulator II | AN |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+49.72% | 87.47M | |
+18.19% | 125B | |
+13.51% | 108B | |
-7.41% | 24.21B | |
+2.07% | 22.78B | |
-10.79% | 17.96B | |
-41.74% | 16.43B | |
-13.23% | 16.37B | |
+1.19% | 13.58B | |
+27.76% | 11.66B |
- Stock Market
- Equities
- POLB Stock
- News Poolbeg Pharma PLC
- Poolbeg Pharma Therapy Shows Efficacy in Lowering Cancer Immunotherapy-induced Cytokine Release Syndrome